PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
13-Oct-2020 NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100(TM) (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19 Relief Therapeutics Holdings AG
13-Oct-2020 Gerresheimer AG: Gerresheimer on track for strong second half-year Gerresheimer AG
13-Oct-2020 Gerresheimer AG: Gerresheimer on track for strong second half-year Gerresheimer AG
13-Oct-2020 Gerresheimer AG: Gerresheimer on track for strong second half-year Gerresheimer AG
13-Oct-2020 Formycon Receives Funding for COVID-19 Drug Research from the Bavarian Research Foundation Formycon AG
13-Oct-2020 NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100(TM) (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19 NeuroRx
13-Oct-2020 Dupixent® (dupilumab) Significantly Reduced Severe Asthma Attacks in Children and is the Only Biologic to Demonstrate Improvement in Children's Lung Function in a Randomized Phase 3 Trial Regeneron Pharmaceuticals, Inc.
13-Oct-2020 Dupixent® (dupilumab) Significantly Reduced Severe Asthma Attacks in Children and is the Only Biologic to Demonstrate Improvement in Children's Lung Function in a Randomized Phase 3 Trial Regeneron Pharmaceuticals, Inc.
12-Oct-2020 MUBADALA INVESTMENT COMPANY AND NOVO HOLDINGS A/S INVEST € 250 M IN EVOTEC SE Evotec SE
12-Oct-2020 Mubadala Investment Company and Novo Holdings A/S invest € 250 million in Evotec SE Evotec SE
12-Oct-2020 Sickle Cell Disease Association of America and Aruvant Sciences Forge New Partnership to Educate Around Gene Therapy Aruvant Sciences
12-Oct-2020 ­­­­SHL Group Deploys Vuzix Smart Glasses for Business Continuity, Training and Remote Inspection Vuzix Corporation
12-Oct-2020 BrainStorm to Present at the 2020 Cell & Gene Meeting on the Mesa Brainstorm Cell Therapeutics Inc
12-Oct-2020 Strategic Investor Active Ownership Group Subscribes for Cash Capital Increase of EUR 25.75 million Formycon AG
12-Oct-2020 Formycon places Cash Capital Increase of 25.75 Million Euros with Strategic Investor Formycon AG
12-Oct-2020 Mallinckrodt Secures Broad Consensus with Key Stakeholders on Comprehensive Chapter 11 Restructuring Mallinckrodt plc
12-Oct-2020 CStone Announces Completion of $200 million Share Sale to Pfizer CStone Pharmaceuticals
12-Oct-2020 CStone Announces Completion of $200 million Share Sale to Pfizer CStone Pharmaceuticals
12-Oct-2020 CStone Announces Completion of $200 million Share Sale to Pfizer CStone Pharmaceuticals
12-Oct-2020 CStone Announces Completion of $200 million Share Sale to Pfizer CStone Pharmaceuticals